MYC and pancreatic ductal adenocarcinoma: Overexpression of c-myc mRNA [30] and protein [31] has been found in about 50% and 43.5% of human pancreatic ductal adenocarcinomas, respectively, with about 32.3% of the samples bearing c-myc gene amplification [31].